Lloyd Klickstein is the founder of Versanis Bio. Versanis Bio has raised $70M in total funding. Latest round: Series A. Based in New York, NY.
Lloyd Klickstein is the founder of Versanis Bio, a clinical-stage biopharmaceutical company focusing on cardiometabolic disease treatments. He has served as the Co-Chief Executive Officer since the company's founding in 2021. Versanis Bio's main asset, bimagrumab, is currently in a Phase 2b study for obesity treatment.
Full founder directory · Investor directory · Company funding database · Fundraising library